Publications by authors named "Ilana Grabenstein"
Article Synopsis
- Hypoalbuminemia, or low albumin levels, in critically ill patients, particularly those with cardiac issues, is linked to higher mortality rates, especially when undergoing veno-arterial (V-A) ECMO treatment.
- A study analyzed albumin levels in 318 patients needing V-A ECMO, finding that those with pre-ECMO albumin levels ≤3 g/dL had a significantly higher in-hospital mortality rate (44.9%) compared to those with higher levels (27.5%).
- The research suggests that lower pre-ECMO albumin levels are correlated with not only increased mortality but also more complications, like the need for platelet transfusions and gastrointestinal bleeding, indicating that albumin levels could
Background: The mortality benefit of VV-ECMO in ARDS has been extensively studied, but the impact on long-term functional outcomes of survivors is poorly defined. We aimed to assess the association between ECMO and functional outcomes in a contemporaneous cohort of survivors of ARDS.
Methods: Multicenter retrospective cohort study of ARDS survivors who presented to follow-up clinic.